Allelic loss at chromosome 11q13 alters FGF3 gene expression in a human breast cancer progression model

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2445-2452

  Roy, Debasish ^a   Calaf, Gloria M ^b,c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSIDAD DE TARAPACÁ   (Chile)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

High LET radiation; Loss of heterozygosity; Microarray; Microsatellite instability; Single strand conformation polymorphism

Indexed keywords

ESTROGEN; FIBROBLAST GROWTH FACTOR 3; MESSENGER RNA; FGF3 PROTEIN, HUMAN;

ALPHA RADIATION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CHROMOSOME 11Q; CONTROLLED STUDY; DRUG TARGETING; FIBROBLAST GROWTH FACTOR 3 GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IONIZING RADIATION; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; BREAST TUMOR; CHROMOSOME 11; CHROMOSOME DELETION; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; DISEASE PROGRESSION; FEMALE; FIBROBLAST GROWTH FACTOR 3; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE INSTABILITY;

EID: 84914708073     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3502     Document Type: Article

References (50)

1. Levine AJ: The tumor suppressor genes. Annu Rev Biochem 62: 623-651, 1993.
2. Knudson AG Jr: Genetics and etiology of human cancer. Adv Hum Genet 8: 1-66, 1977.
3. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823, 1971.
4. Wolman SR, Pauley RJ, Mohamad AN, Dawson PJ, Visscher DW and Sarkar FH: Genetic markers as prognostic indicators in breast cancer. Cancer 70: 1765-1774, 1992.
5. Mitelman F: Catalogue of Chromosome Aberration in Cancer. 4th edition. Willey-Liss, New York, NY, 1991.
6. Lengauer C, Kinzler KW and Vogelstein B: Genetic instabilities in human cancers. Nature 396: 643-649, 1998.
7. Devilee P, Van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL and Cornelisse CJ: At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5: 554-560, 1989
8. Anderson TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM and Borresen AL: Genetic alterations of the tumor suppressor gene regions 3p, 11p, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer 4: 113-121, 1992.
9. Roy D, Calaf G and Hei TK: Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells. Carcinogenesis 22: 1685-1692, 2001.
10. Winqvist R, Manner Maa A, Alavaik Ko M, Blanco G, Kiviniemi H, Taskinen PJ, Kiviniemi H, Newsham I and Cavenee W: Refinement of regional loss of heterozygosity for 11p15.5 in human breast tumors. Cancer Res 53: 4486-4488, 1993.
11. Hampton G, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee W and Evans GA: Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 54: 4586-4589, 1994.
12. Negrini M, Sabbioni S, Possati L, Rattan S, Corallini A, Barbanti-Brodano G and Croce CM: Suppression of tumorigenecity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosome 6 and 11. Cancer Res 54: 1331-1336, 1994.
13. Rosa-Rosa JM, Pita G, González-Neira A, Milne RL, Fernandez V, Ruivenkamp C, van Asperen CJ, Devilee P and Benitez J: A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer. Breast Cancer Res Treat 118: 151-159, 2009.
14. Karlsson E, Waltersson MA, Bostner J, Pérez-Tenorio G, Olsson B, Hallbeck AL and Stäl O: High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1. Genes Chromosomes Cancer 50: 775-787, 2011.
15. Lizard-Nacol S, Lidereau R, Collin FA, Arnal M, Hahnel L, Roignot P, Cuisenier, J and Guerrin J: Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy. Cancer Res 55: 4416-4419, 1995.
16. Fantl V, Smith R, Brookes S, Dickson C and Peters G: Chromosome 11q13 abnormalities in human breast cancer. Cancer Surv 18: 77-94, 1993.
17. Champème MH, Bièche I, Hacène K and Lidereau R: Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer. Mod Pathol 7: 900-905, 1994.
18. Roy D, Calaf GM, Hande MP and Hei TK: Allelic imbalance at 11q23-q24 chromosome associated with estrogen and radiation-induced breast cancer progression. Int J Oncol 28: 667-674, 2006.
19. Calaf GM and Hei TK: Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis 21: 769-776, 2000.
20. Soule H, Vazquez J, Long A, Albert S and Brennan MA: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416, 1973.
21. Roy D, Calaf GM and Hei TK: Profiling of differentially expressed genes induced by high linear energy transfer radiation in breast epithelial cells. Mol Carcinogen 31: 192-203, 2001.
22. Roy D, Calaf G and Hei TK: Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-ras mutation during radiation-induced neoplastic transformation of human breast epithelial cells. Int J Cancer 103: 730-737, 2003.
23. Calaf GM, Roy D and Hei TK: Immunochemical analysis of protein expression in breast epithelial cells transformed by estrogens and high linear energy transfer (LET) radiation. Histochem Cell Biol 124: 261-274, 2005.
24. Calaf G and Hei TK: Oncoprotein expression in human breast epithelial cells transformed by high-LET radiation. Int J Radiat Biol 77: 31-40, 2001.
25. Gross-Bellard M, Oudet P and Chambon P: Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 36: 32-38, 1973.
26. Sambrook J, Fritsch EF and Maniatis T (eds): Molecular Cloning. A Laboratory Manual. Vol 3, 2nd edition. Cold Spring Harbor Laboratory Press, Plainview, NY, pp 1626, 1989.
27. Jaeckel S, Epplen JT, Kauth M, Miterski B, Tschentscher F and Epplen C: Polymerase chain reaction-single strand conformation polymorphism or how to detect reliably and efficiently each sequence variation in many samples and many genes. Electrophoresis 19: 3055-3061, 1998.
28. Calaf GM and Roy D: Gene and protein expressions induced by 17beta-estradiol and parathion in cultured breast epithelial cells. Mol Med 13: 255-265, 2007.
29. Calaf GM and Roy D: Cell adhesion proteins altered by 17β estradiol and parathion in breast epithelial cells. Oncol Rep 19: 165-169, 2008.
30. Califano A: SPLASH: structural pattern localization analysis by sequential histograms. Bioinformatics 16: 341-357, 2000.
31. Calaf GM, Roy D, Narayan G and Balajee AS: Differential expression of cell adhesion molecules in an ionizing radiation-induced breast cancer model system. Oncol Rep 30: 285-291, 2013.
32. Bieche I and Lidereau R: Genetic alterations in breast cancer. Genes Chromosomes Cancer 14: 227-251, 1995.
33. + tumor cells. Cell 75: 1227-1236, 1993.
34. Dedhar S: Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol 12: 250-256, 2000.
35. Hilakivi-Clarke L: Estrogens, BRCA1, and breast cancer. Cancer Res 60: 4993-5001, 2000.
36. Liehr JG: Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21: 40-54, 2000.
37. Berkey CS, Frazier AL, Gardner JD and Colditz GA: Adolescence and breast carcinoma risk. Cancer 85: 2400-2409, 1999.
38. Nagahata T, Hirano A, Utada Y, Tsuchiya S, Takahashi K, Tada T, Makita M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y and Emi M: Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers. Breast Cancer 9: 208-215, 2002.
39. Wilkerson PM and Reis-Filho JS: The 11q13-q14 amplicon: clinicopathological correlations and potential drivers. Genes Chromosomes Cancer 52: 333-355, 2013.
40. Holm K, Staaf J, Jönsson G, Vallon-Christersson J, Gunnarsson H, Arason A, Magnusson L, Barkardottir RB, Hegardt C, Ringnér M, and Borg A: Characterization of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumors. Breast Cancer Res Treat 133: 583-594, 2012.
41. Saxon PJ, Srivatsan ES and Stanbridge EJ: Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J 5: 3461-3466, 1986.
42. Shi ZZ, Jiang YY, Hao JJ, Zhang Y, Zhang TT, Shang L, Liu SG, Shi F and Wang MR: Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinoma. Clin Transl Oncol 8: 606-615, 2013.
43. Jarmuz-Szymczak M, Pelinska K, Kostrzewska-Poczekaj M, Bembnista E, Giefing M, Brauze D, Szaumkessel M, Marszalek A, Janiszewska J, Kiwerska K, Bartochowska A, Grenman R, Szyfter W and Szyfter K: Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization. Mol Biol Rep 40: 4161-4171, 2013.
44. Su T, Han Y, Yu Y, Tan X, Li X, Hou J, Du Y, Shen J, Wang G, Ma L, Jiang S, Zhang H and Cao G: A GWAS-identified susceptibility locus on chromosome 11q13.3 and its putative molecular target for prediction of postoperative prognosis of human renal cell carcinoma. Oncol Lett 6: 421-426, 2013.
45. Chung CC, Boland J, Yeager M, Jacobs KB, Zhang X, Deng Z, Matthews C, Berndt SI and Chanock SJ: Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer. Prostate 72: 476-486, 2012.
46. Champème MH, Bièche I, Lizard S and Lidereau R: 11q13 amplification in local recurrence of human primary breast cancer. Genes Chromosomes Cancer 12: 128-133, 1995.
47. Feinberg AP: Genomic imprinting and gene activation in cancer. Nat Genet 4: 110-113, 1993.
48. Naidu R, Wahab NA, Yadav M, Kutty MK and Nair S: Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction. Int J Mol Med 8: 193-198, 2001.
49. Hajitou A, Deroanne C, Noël A, Collette J, Nusgens B, Foidart JM and Calberg-Bacq CM: Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4. Breast Cancer Res Treat 60: 15-28, 2000.
50. Dienstmann R, Rodon J, Prat A, Perez-Garcia J, Adamo B, Felip E, Cortes J, Iafrate AJ, Nuciforo P and Tabernero J: Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors. Ann Oncol 20: 552-563, 2014.